Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03620474

Recruitment Status : Active, not recruiting

First Posted : August 8, 2018

Last Update Posted : April 6, 2021

Sponsor:

Collaborators:

PRISM BioLab Co.,Ltd.

Kyushu University

National Center for Global Health and Medicine, Japan

Japan Agency for Medical Research and Development

Ohara Pharmaceutical Co., Ltd.

Information provided by (Responsible Party):

Kiminori Kimura, MD, Komagome Hospital

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	March 2022
Estimated Study Completion Date :	March 2022

To Top